Literature DB >> 21482377

Obstetric outcomes of pregnancy after conservative treatment of endometrial cancer: case series and literature review.

An-Shine Chao1, Angel Chao, Chin-Jung Wang, Chyong-Huey Lai, Hsin-Shih Wang.   

Abstract

OBJECTIVE: To evaluate the pregnancy courses and obstetric outcomes in patients conceived after conservative treatment of endometrial cancer.
MATERIALS AND METHODS: Case series and systemic review of pregnancy women after fertility-sparing treatment of endometrial cancer. Patients with early stage endometrial cancer were identified through Tumor Registry in Chang Gung Memorial Hospital between 1990 and 2005 and MEDLINE search. Diagnosed cases were managed by fertility-sparing therapies. Pregnancies followed by assisted reproductive technology and spontaneous or ovulation with intrauterine insemination were designated as Group 1 and Group 2, respectively.
RESULTS: Five livebirths in three patients with two sets of twin pregnancy were delivered. Adding 47 women in the MEDLINE search literature, there were 65 deliveries with 77 livebirths. Groups 1 and 2 had 15 and 50 deliveries, respectively. Group 1 had 23 livebirths including four sets of twins and two sets of triplets, whereas 54 livebirths consisted of two sets of twins and one set of triplets were noted in Group 2 (p = 0.003). Seven preterm deliveries were noted in Group 1 and three in Group 2 (p = 0.001). Cesarean rate was 93.3% versus 22.0% (p < 0.001) in Groups 1 and 2, respectively. Pregnancy-induced hypertension and gestational diabetes mellitus were significant between the two groups (p = 0.035). One mother died of disease after delivery. No neonatal morbidity was reported.
CONCLUSIONS: For women who had completed conservative treatments in early endometrial cancer, assisted reproductive technology provided a choice of scheduled conception for those with subfertility or chronic anovulation.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21482377     DOI: 10.1016/j.tjog.2009.10.006

Source DB:  PubMed          Journal:  Taiwan J Obstet Gynecol        ISSN: 1028-4559            Impact factor:   1.705


  7 in total

1.  Analysis of Factors Associated With Recurrence of Early-Stage Endometrial Carcinoma and Atypical Endometrial Hyperplasia in Infertile Women After In Vitro Fertilization Treatment.

Authors:  Yaxing Guo; Xuan Zong; Hongzhen Li; Jie Qiao
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

2.  Cancer, fertility preservation, and future pregnancy: a comprehensive review.

Authors:  Michelle L Matthews; Bradley S Hurst; Paul B Marshburn; Rebecca S Usadi; Margaret A Papadakis; Terry Sarantou
Journal:  Obstet Gynecol Int       Date:  2012-03-18

Review 3.  Preserving fertility in young patients with endometrial cancer: current perspectives.

Authors:  Eleftheria Kalogera; Sean C Dowdy; Jamie N Bakkum-Gamez
Journal:  Int J Womens Health       Date:  2014-07-29

4.  ESHRE guideline: female fertility preservation.

Authors:  Richard A Anderson; Frédéric Amant; Didi Braat; Arianna D'Angelo; Susana M Chuva de Sousa Lopes; Isabelle Demeestere; Sandra Dwek; Lucy Frith; Matteo Lambertini; Caroline Maslin; Mariana Moura-Ramos; Daniela Nogueira; Kenny Rodriguez-Wallberg; Nathalie Vermeulen
Journal:  Hum Reprod Open       Date:  2020-11-14

Review 5.  Fertility Sparing Treatments in Endometrial Cancer Patients: The Potential Role of the New Molecular Classification.

Authors:  Anna Franca Cavaliere; Federica Perelli; Simona Zaami; Marco D'Indinosante; Irene Turrini; Marco Giusti; Giuseppe Gullo; Giuseppe Vizzielli; Alberto Mattei; Giovanni Scambia; Annalisa Vidiri; Fabrizio Signore
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

Review 6.  Fertility issue in early stage endometrial cancer patients.

Authors:  Hasan Onur Topçu; Cihan Kaya; Engin Oral
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

7.  Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia.

Authors:  Yuan Fan; Xingchen Li; Jiaqi Wang; Yiqin Wang; Li Tian; Jianliu Wang
Journal:  Reprod Biol Endocrinol       Date:  2021-08-03       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.